High Tide's Q1 Mixes Remexian Recovery with Retail Slowdown, Testing Core Investment Thesis

What happened

High Tide reported mixed Q1 financials, with overall good performance but a hiccup in Canna Cabana's same-store sales due to a market slowdown. The company's Remexian distribution business in Germany is recovering well from supply chain issues in Portugal, indicating progress in scaling international operations. This follows FY2025 results that showed record revenue, positive adjusted EBITDA for 22 consecutive quarters, and free cash flow of $12.0 million, as highlighted in the DeepValue report. However, the retail slowdown raises concerns about the durability of Canada same-store sales, a key pillar of the investment thesis reliant on sustained comps. Investors now face a critical period where management must prove that distribution gains can offset retail weaknesses without compromising cash flow or restarting equity dilution.

Implication

Remexian's recovery suggests Germany distribution is scaling, which could boost future cash flows if working capital is managed without dilution. The Canna Cabana slowdown may indicate market saturation or competitive pressures, threatening store-level economics and the core profit engine. Management's ability to sustain positive operating cash flow while expanding Remexian without ATM issuance is now paramount to avoid the bear scenario. If Q1 cash flow remains positive, it could validate the base case; if negative, it risks forcing equity issuance and driving downside toward $1.70. Investors should await detailed Q1 filings to assess working capital impacts and adjust positions based on cash flow resilience and any signs of dilution.

Thesis delta

The new Q1 data introduces a negative shift in the Canada retail pillar due to same-store sales deceleration, challenging the assumption that comps will persist. However, it provides a positive shift in the Germany distribution pillar with Remexian's recovery, supporting international scaling. Overall, the thesis remains intact but with increased uncertainty, requiring heightened vigilance on cash flow and dilution risks over the next quarter.